The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
The NMDA Receptor and Schizophrenia
Open accessAbstract
Schizophrenia is a severe mental illness that affects almost 1% of the population worldwide. Even though the etiology of schizophrenia is uncertain, it is believed to be a neurodevelopmental disorder that results from a combination of environmental insults and genetic vulnerabilities. Over the past 20 years, there has been a confluence of evidence from many research disciplines pointing to alterations in excitatory signaling, particularly involving hypofunction of the N-methyl-D-aspartate receptor (NMDAR), as a key contributor to the schizophrenia disease process. This review describes the structure-function relationship of the NMDAR channel and how the glycine modulatory site (GMS) acts as an important regulator of its activity. In addition, this review highlights the genetic, pharmacologic, and biochemical evidence supporting the hypothesis that NMDAR hypofunction contributes to the pathophysiology of schizophrenia. Finally, this chapter highlights some of the most recent and promising pharmacological strategies that are designed to either, directly or indirectly, augment NMDAR function in an effort to treat the cognitive and negative symptoms of schizophrenia that are not helped by currently available medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,139
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,435
Schizophrenia risk from complex variation of complement component 4
Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. (2016) · Nature · doi:10.1038/nature16549 · Cited by 2,394
De novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population
Perälä, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K., Isometsä, E., Pirkola, S., Partonen, T., Tuulio-Henriksson, A., Hintikka, J., Kieseppä, T., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.19 · Cited by 1,516
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Requirement for Glycine in Activation of NMDA-Receptors Expressed in Xenopus Oocytes
Kleckner, N. W., & Dingledine, R. (1988) · Science · doi:10.1126/science.2841759 · Cited by 1,422
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Boehning, D., & Snyder, S. H. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131047 · Cited by 1,225
Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197
Jones, P. B., Barnes, T. R. E., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., Murray, R. M., Markwick, A., & Lewis, S. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1079 · Cited by 1,105
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Kirov, G., Pocklington, A. J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Moran, J., Chambert, K., Toncheva, D., Georgieva, L., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.154 · Cited by 844 · cited 2×
“Copy number variants (CNVs) (stretches of DNA that are either deleted or duplicated) and rare exonic variants can also lead to increased genetic risk for schizophrenia (Fromer et al., 2014; Kirov et al., 2012).”
BackgroundSchell, M. J., Molliver, M. E., & Snyder, S. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3948 · Cited by 832
Wolosker, H., Blackshaw, S., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13409 · Cited by 811
Lewis, D. A., & Lieberman, J. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)00111-2 · Cited by 811
Heritability Estimates for Psychotic Disorders: The Maudsley Twin Psychosis Series
Cardno, A. G., Marshall, E. J., Coid, B., Macdonald, A. M., Ribchester, T. R., Davies, N. J., Venturi, P., Jones, L. A., Lewis, S. W., Sham, P. C., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.162 · Cited by 797
Neurodevelopmental model of schizophrenia: update 2012
Rapoport, J. L., Giedd, J. N., & Gogtay, N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.23 · Cited by 790
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium (2015) · Nature Neuroscience · doi:10.1038/nn.3922 · Cited by 755
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
Papouin, T., Ladépêche, L., Ruel, J., Sacchi, S., Labasque, M., Hanini, M., Groc, L., Pollegioni, L., Mothet, J.-P., & Oliet, S. H. R. (2012) · Cell · doi:10.1016/j.cell.2012.06.029 · Cited by 754
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
Belforte, J. E., Zsiros, V., Sklar, E. R., Jiang, Z., Yu, G., Li, Y., Quinlan, E. M., & Nakazawa, K. (2010) · Nature Neuroscience · doi:10.1038/nn.2447 · Cited by 752
Kessler, M., Terramani, T., Lynch, G., & Baudry, M. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb01881.x · Cited by 739
Effects of Ketamine in Normal and Schizophrenic Volunteers
Lahti, A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00243-3 · Cited by 674
Greer, P. L., & Greenberg, M. E. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.002 · Cited by 661 · cited 1×
“UponNMDARchannel opening, Ca2+ enters the neuron and triggers a cascade of intracellular events that mediate local, acute functional synaptic plasticity and changes in gene expression that influence long-term neural structural plasticity (Greer & Greenberg, 2008).”
BackgroundMuscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Crystal structure of a heterotetrameric NMDA receptor ion channel
Karakas, E., & Furukawa, H. (2014) · Science · doi:10.1126/science.1251915 · Cited by 603
Meltzer, H. Y. (1989) · Psychopharmacology · doi:10.1007/bf00442554 · Cited by 602
Increased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., & Javitt, D. C. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.12.1139 · Cited by 583
The Hippocampal Formation in Schizophrenia
Tamminga, C. A., Stan, A. D., & Wagner, A. D. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09081187 · Cited by 582
Dendritic spine pathology in schizophrenia
Glausier, J. R., & Lewis, D. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.044 · Cited by 581
Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
Shekhar, A., Potter, W. Z., Lightfoot, J., Lienemann, J., Dubé, S., Mallinckrodt, C., Bymaster, F. P., McKinzie, D. L., & Felder, C. C. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.06091591 · Cited by 560
Fusar-Poli, P., Smieskova, R., Kempton, M. J., Ho, B. C., Andreasen, N. C., & Borgwardt, S. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.001 · Cited by 512
Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
Lesh, T. A., Niendam, T. A., Minzenberg, M. J., & Carter, C. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.156 · Cited by 506
Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia
Gonzalez-Burgos, G., Cho, R. Y., & Lewis, D. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.010 · Cited by 497
Sikich, L., Frazier, J. A., McClellan, J., Findling, R. L., Vitiello, B., Ritz, L., Ambler, D., Puglia, M., Maloney, A. E., Michael, E., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050756 · Cited by 478
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L. H., & Engberg, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02242-x · Cited by 471
Mothet, J.-P., Pollegioni, L., Ouanounou, G., Martineau, M., Fossier, P., & Baux, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408483102 · Cited by 460
Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies
Marsman, A., van den Heuvel, M. P., Klomp, D. W. J., Kahn, R. S., Luijten, P. R., & Hulshoff Pol, H. E. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr069 · Cited by 457
Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081358 · Cited by 419
Modulation of N -methyl- d -aspartate receptor function by glycine transport
Bergeron, R., Meyer, T. M., Coyle, J. T., & Greene, R. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15730 · Cited by 411
Steiner, J., Walter, M., Glanz, W., Sarnyai, Z., Bernstein, H.-G., Vielhaber, S., Kästner, A., Skalej, M., Jordan, W., Schiltz, K., et al. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.86 · Cited by 380
Prefrontal Cortical Dendritic Spine Pathology in Schizophrenia and Bipolar Disorder
Konopaske, G. T., Lange, N., Coyle, J. T., & Benes, F. M. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1582 · Cited by 379
Immunocytochemical localization of serotonin1A receptors in the rat central nervous system
Kia, H. K., Miquel, M.-C., Brisorgueil, M.-J., Daval, G., Riad, M., Mestikawy, S. E., Hamon, M., & Verg�, D. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960205)365:2<289::aid-cne7>3.0.co;2-1 · Cited by 378
Kegeles, L. S., Abi-Dargham, A., Zea-Ponce, Y., Rodenhiser-Hill, J., Mann, J. J., Van Heertum, R. L., Cooper, T. B., Carlsson, A., & Laruelle, M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00976-8 · Cited by 377
Gao, X.-M., Sakai, K., Roberts, R. C., Conley, R. R., Dean, B., & Tamminga, C. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1141 · Cited by 372
Hulshoff Pol, H. E., & Kahn, R. S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm168 · Cited by 364
Lugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., et al. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.07.002 · Cited by 346
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior
Basu, A. C., Tsai, G. E., Ma, C.-L., Ehmsen, J. T., Mustafa, A. K., Han, L., Jiang, Z. I., Benneyworth, M. A., Froimowitz, M. P., Lange, N., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.130 · Cited by 338
Neuroanatomy of vulnerability to psychosis: A voxel-based meta-analysis
Fusar-Poli, P., Borgwardt, S., Crescini, A., Deste, G., Kempton, M. J., Lawrie, S., Mc Guire, P., & Sacchetti, E. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.12.005 · Cited by 332
A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia
BENDIKOV, I., NADRI, C., AMAR, S., PANIZZUTTI, R., DEMIRANDA, J., WOLOSKER, H., & AGAM, G. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.10.010 · Cited by 323
Evaluating historical candidate genes for schizophrenia
Farrell, M. S., Werge, T., Sklar, P., Owen, M. J., Ophoff, R. A., O'Donovan, M. C., Corvin, A., Cichon, S., & Sullivan, P. F. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.16 · Cited by 315
d‐Amino acids in the brain:d‐serine in neurotransmission and neurodegeneration
Wolosker, H., Dumin, E., Balan, L., & Foltyn, V. N. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06515.x · Cited by 309
Hansen, K. B., Ogden, K. K., Yuan, H., & Traynelis, S. F. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.035 · Cited by 305
Localization of the GLYT1 Glycine Transporter at Glutamatergic Synapses in the Rat Brain
Cubelos, B. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhh147 · Cited by 288
Neuron-derived D-Serine Release Provides a Novel Means to Activate N-Methyl-D-aspartate Receptors
Kartvelishvily, E., Shleper, M., Balan, L., Dumin, E., & Wolosker, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512927200 · Cited by 279
Marino, M. J., Rouse, S. T., Levey, A. I., Potter, L. T., & Conn, P. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11465 · Cited by 275
Tsai, G., & Lin, P.-Y. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361452 · Cited by 269
Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindström, L. H., & Iyo, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.023 · Cited by 267
Paul, S. M., Doherty, J. J., Robichaud, A. J., Belfort, G. M., Chow, B. Y., Hammond, R. S., Crawford, D. C., Linsenbardt, A. J., Shu, H.-J., Izumi, Y., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2619-13.2013 · Cited by 264
Priestley, T., Laughton, P., Myers, J., Le Bourdellés, B., Kerby, J., & Whiting, P. J. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10541-5 · Cited by 260
Zafra, F., Gomeza, J., Olivares, L., Aragón, C., & Giménez, C. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01125.x · Cited by 259
Kinon, B. J., Zhang, L., Millen, B. A., Osuntokun, O. O., Williams, J. E., Kollack-Walker, S., Jackson, K., Kryzhanovskaya, L., & Jarkova, N. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318218dcd5 · Cited by 256
A Role for Noncoding Variation in Schizophrenia
Roussos, P., Mitchell, A. C., Voloudakis, G., Fullard, J. F., Pothula, V. M., Tsang, J., Stahl, E. A., Georgakopoulos, A., Ruderfer, D. M., Charney, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.015 · Cited by 251
Changes in the adolescent brain and the pathophysiology of psychotic disorders
Keshavan, M. S., Giedd, J., Lau, J. Y. F., Lewis, D. A., & Paus, T. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00081-9 · Cited by 249
Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1213 · Cited by 243
Serine racemase is predominantly localized in neurons in mouse brain
Miya, K., Inoue, R., Takata, Y., Abe, M., Natsume, R., Sakimura, K., Hongou, K., Miyawaki, T., & Mori, H. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21822 · Cited by 242
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
Weickert, C. S., Fung, S. J., Catts, V. S., Schofield, P. R., Allen, K. M., Moore, L. T., Newell, K. A., Pellen, D., Huang, X.-F., Catts, S. V., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.137 · Cited by 236
Lane, H.-Y., Lin, C.-H., Green, M. F., Hellemann, G., Huang, C.-C., Chen, P.-W., Tun, R., Chang, Y.-C., & Tsai, G. E. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2159 · Cited by 229
Kempton, M. J., Stahl, D., Williams, S. C. R., & DeLisi, L. E. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.03.036 · Cited by 228
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses
Law, A. J., & Deakin, J. F. W. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00043 · Cited by 227
Serotonin 5-HT1A Receptors Regulate NMDA Receptor Channels through a Microtubule-Dependent Mechanism
Yuen, E. Y. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1187-05.2005 · Cited by 225
Jones, C. K., Byun, N., & Bubser, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.199 · Cited by 225
Selvaraj, S., Arnone, D., Cappai, A., & Howes, O. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.005 · Cited by 223
de Miranda, J., Panizzutti, R., Foltyn, V. N., & Wolosker, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222421299 · Cited by 221
Anti-NMDA receptor encephalitis, autoimmunity, and psychosis
Kayser, M. S., & Dalmau, J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.007 · Cited by 220
Serine Racemase Modulates Intracellular D-Serine Levels through an α,β-Elimination Activity
Foltyn, V. N., Bendikov, I., De Miranda, J., Panizzutti, R., Dumin, E., Shleper, M., Li, P., Toney, M. D., Kartvelishvily, E., & Wolosker, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m405726200 · Cited by 219
Balu, D. T., Li, Y., Puhl, M. D., Benneyworth, M. A., Basu, A. C., Takagi, S., Bolshakov, V. Y., & Coyle, J. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304308110 · Cited by 217
Self-citationExpression and Signaling of Group I Metabotropic Glutamate Receptors in Astrocytes and Microglia
Biber, K., Laurie, D. J., Berthele, A., Sommer, B., Tölle, T. R., Gebicke‐Härter, P., Van Calker, D., & Boddeke, H. W. G. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721671.x · Cited by 217
Prickaerts, J., van Goethem, N. P., Chesworth, R., Shapiro, G., Boess, F. G., Methfessel, C., Reneerkens, O. A. H., Flood, D. G., Hilt, D., Gawryl, M., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.024 · Cited by 204
Quartermain, D., Mower, J., Rafferty, M. F., Herting, R. L., & Lanthorn, T. H. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90687-4 · Cited by 190
Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex
Fossat, P., Turpin, F. R., Sacchi, S., Dulong, J., Shi, T., Rivet, J.-M., Sweedler, J. V., Pollegioni, L., Millan, M. J., Oliet, S. H. R., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr130 · Cited by 187
Catts, V. S., Lai, Y. L., Weickert, C. S., Weickert, T. W., & Catts, S. V. (2015) · Biological Psychology · doi:10.1016/j.biopsycho.2015.10.013 · Cited by 183
Inflammation in schizophrenia: A question of balance
Leza, J. C., García-Bueno, B., Bioque, M., Arango, C., Parellada, M., Do, K., O’Donnell, P., & Bernardo, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.014 · Cited by 182
Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia
Balu, D. T., & Coyle, J. T. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.005 · Cited by 181
Self-citationReduction of Brain Kynurenic Acid Improves Cognitive Function
Kozak, R., Campbell, B. M., Strick, C. A., Horner, W., Hoffmann, W. E., Kiss, T., Chapin, D. S., McGinnis, D., Abbott, A. L., Roberts, B. M., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1107-14.2014 · Cited by 180
Storage and Uptake of d-Serine into Astrocytic Synaptic-Like Vesicles Specify Gliotransmission
Martineau, M., Shi, T., Puyal, J., Knolhoff, A. M., Dulong, J., Gasnier, B., Klingauf, J., Sweedler, J. V., Jahn, R., & Mothet, J.-P. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3497-12.2013 · Cited by 172
The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
Verrall, L., Burnet, P. W. J., Betts, J. F., & Harrison, P. J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.99 · Cited by 170
Canu, E., Agosta, F., & Filippi, M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.020 · Cited by 170
Keefe, R. S. E., Meltzer, H., Dgetluck, N., Gawryl, M. S., Koenig, G., Moebius, H. J., Lombardo, I., & Hilt, D. C. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.176 · Cited by 161
Serine racemase and the serine shuttle between neurons and astrocytes
Wolosker, H. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.01.001 · Cited by 159
Benneyworth, M. A., Li, Y., Basu, A. C., Bolshakov, V. Y., & Coyle, J. T. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9808-4 · Cited by 159
Albuquerque, E. X., & Schwarcz, R. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.014 · Cited by 153
Yang, J. H., Wada, A., Yoshida, K., Miyoshi, Y., Sayano, T., Esaki, K., Kinoshita, M. O., Tomonaga, S., Azuma, N., Watanabe, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187443 · Cited by 153
Kantrowitz, J. T., Woods, S. W., Petkova, E., Cornblatt, B., Corcoran, C. M., Chen, H., Silipo, G., & Javitt, D. C. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00098-x · Cited by 148
Glycine transporters: essential regulators of synaptic transmission
Betz, H., Gomeza, J., Armsen, W., Scholze, P., & Eulenburg, V. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340055 · Cited by 148
Human serine racemase: moleular cloning, genomic organization and functional analysis
Miranda, J. D., Santoro, A., Engelender, S., & Wolosker, H. (2000) · Gene · doi:10.1016/s0378-1119(00)00356-5 · Cited by 146
Rook, J. M., Xiang, Z., Lv, X., Ghoshal, A., Dickerson, J. W., Bridges, T. M., Johnson, K. A., Foster, D. J., Gregory, K. J., Vinson, P. N., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.063 · Cited by 142
Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia
Jadi, M. P., Behrens, M. M., & B, T. J. S. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.005 · Cited by 137
Myelin, myelin-related disorders, and psychosis
Mighdoll, M. I., Tao, R., Kleinman, J. E., & Hyde, T. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.040 · Cited by 135
Pearlman, D. M., & Najjar, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.001 · Cited by 132
d-Serine and Serine Racemase are Localized to Neurons in the Adult Mouse and Human Forebrain
Balu, D. T., Takagi, S., Puhl, M. D., Benneyworth, M. A., & Coyle, J. T. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0027-z · Cited by 130
Self-citationKarlsgodt, K. H., Robleto, K., Trantham‐Davidson, H., Jairl, C., Cannon, T. D., Lavín, A., & Jentsch, J. D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.012 · Cited by 125
Yuen, E. Y., Jiang, Q., Chen, P., Feng, J., & Yan, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801713200 · Cited by 125
Meltzer, H. Y., Rajagopal, L., Huang, M., Oyamada, Y., Kwon, S., & Horiguchi, M. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000928 · Cited by 122
Choi, K., Wykes, T., & Kurtz, M. M. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107359 · Cited by 120
A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia
Morita, Y., Ujike, H., Tanaka, Y., Otani, K., Kishimoto, M., Morio, A., Kotaka, T., Okahisa, Y., Matsushita, M., Morikawa, A., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.025 · Cited by 119
D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase
Ehmsen, J. T., Ma, T. M., Sason, H., Rosenberg, D., Ogo, T., Furuya, S., Snyder, S. H., & Wolosker, H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4914-12.2013 · Cited by 118
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology
DeVito, L. M., Balu, D. T., Kanter, B. R., Lykken, C., Basu, A. C., COYLE, J. T., & Eichenbaum, H. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00656.x · Cited by 114
Self-citationGhoshal, A., Rook, J. M., Dickerson, J. W., Roop, G. N., Morrison, R. D., Jalan‐Sakrikar, N., Lamsal, A., Noetzel, M. J., Poslusney, M. S., Wood, M. R., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.189 · Cited by 111
Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex
Henson, M. A., Roberts, A. C., Salimi, K., Vadlamudi, S., Hamer, R. M., Gilmore, J. H., Jarskog, L. F., & Philpot, B. D. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn017 · Cited by 110
Meltzer, H. Y. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1088-0 · Cited by 109
Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function
Balu, D. T., Carlson, G. C., Talbot, K., Kazi, H., Hill‐Smith, T. E., Easton, R. M., Birnbaum, M. J., & Lucki, I. (2010) · Hippocampus · doi:10.1002/hipo.20887 · Cited by 108
Self-citationA Selective Review of Volumetric and Morphometric Imaging in Schizophrenia
Levitt, J. J., Bobrow, L., Lucia, D., & Srinivasan, P. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_53 · Cited by 105
Carlson, G. C., Talbot, K., Halene, T. B., Gandal, M. J., Kazi, H. A., Schlosser, L., Phung, Q. H., Gur, R. E., Arnold, S. E., & Siegel, S. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109625108 · Cited by 103
Bugarski‐Kirola, D., Wang, A., Abi‐Saab, D., & Blaettler, T. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.007 · Cited by 103
Tatard-Leitman, V. M., Jutzeler, C. R., Suh, J., Saunders, J. A., Billingslea, E. N., Morita, S., White, R. S., Featherstone, R. E., Ray, R., Ortinski, P. I., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.026 · Cited by 102
Walker, A. G., Wenthur, C. J., Xiang, Z., Rook, J. M., Emmitte, K. A., Niswender, C. M., Lindsley, C. W., & Conn, P. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416196112 · Cited by 100
Iwata, Y., Nakajima, S., Suzuki, T., Keefe, R. S. E., Plitman, E., Chung, J. K., Caravaggio, F., Mimura, M., Graff‐Guerrero, A., & Uchida, H. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.68 · Cited by 97
Radant, A. D., Bowdle, T. A., Cowley, D. S., Kharasch, E. D., & Roy-Byrne, P. P. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00030-x · Cited by 97
Steiner, J., Teegen, B., Schiltz, K., Bernstein, H., Stoecker, W., & Bogerts, B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.469 · Cited by 93
Pershing, M. L., Bortz, D. M., Pocivavsek, A., Fredericks, P. J., Jørgensen, C. V., Vunck, S. A., Leuner, B., Schwarcz, R. M., & Bruno, J. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.017 · Cited by 92
Stan, A. D., Ghose, S., Zhao, C., Hulsey, K., Mihalakos, P., Yanagi, M., Morris, S., Bartko, J. J., Choi, C., & Tamminga, C. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.54 · Cited by 88
Crystal Structure of a Homolog of Mammalian Serine Racemase from Schizosaccharomyces pombe
Goto, M., Yamauchi, T., Kamiya, N., MIYAHARA, I., Yoshimura, T., Mihara, H., Kurihara, T., Hirotsu, K., & Esaki, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010470 · Cited by 87
Hamase, K., Konno, R., Morikawa, A., & Zaitsu, K. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1578 · Cited by 86
GluN3A: An NMDA Receptor Subunit with Exquisite Properties and Functions
Kehoe, L. A., Bernardinelli, Y., & Müller, D. (2013) · Neural Plasticity · doi:10.1155/2013/145387 · Cited by 85
Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
Coyle, J. T., Balu, D. T., Benneyworth, M. A., Basu, A. C., & Roseman, A. S. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/jcoyle · Cited by 84
Self-citationLi, Y., Sacchi, S., Pollegioni, L., Basu, A. C., Coyle, J. T., & Bolshakov, V. Y. (2013) · Nature Communications · doi:10.1038/ncomms2779 · Cited by 82
Curcio, L., Podda, M. V., Leone, L., Piacentini, R., Mastrodonato, A., Cappelletti, P., Sacchi, S., Pollegioni, L., Grassi, C., & D’Ascenzo, M. (2013) · Brain · doi:10.1093/brain/awt036 · Cited by 79
Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
Ellaithy, A., Younkin, J., González‐Maeso, J., & Logothetis, D. E. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.06.002 · Cited by 79
Serine racemase: an unconventional enzyme for an unconventional transmitter
Wolosker, H., & Mori, H. (2012) · Amino Acids · doi:10.1007/s00726-012-1370-3 · Cited by 71
Mice with genetically altered glutamate receptors as models of schizophrenia: A comprehensive review
Inta, D., Monyer, H., Sprengel, R., Meyer‐Lindenberg, A., & Gass, P. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.010 · Cited by 69
Banerjee, A., Wang, H.-Y., Borgmann‐Winter, K. E., MacDonald, M. L., Kaprielian, H., Stucky, A., Kvasic, J., Egbujo, C. N., Ray, R., Talbot, K., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.115 · Cited by 65
Balu, D. T., Li, Y., Takagi, S., Presti, K. T., Ramikie, T. S., Rook, J. M., Jones, C. K., Lindsley, C. W., Conn, P. J., Bolshakov, V. Y., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.2 · Cited by 60
Self-citationNeuronal d-serine regulates dendritic architecture in the somatosensory cortex
Balu, D. T., & Coyle, J. T. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.04.020 · Cited by 57
Self-citationNeuroleptic effects of chlorpromazine in therapeutics of neuropsychiatry.
Delay, J., & Deniker, P. (1955) · PubMed · Cited by 57
Genetic loss of D‐amino acid oxidase activity reverses schizophrenia‐like phenotypes in mice
Labrie, V., Wang, W., Barger, S. W., Baker, G. B., & Roder, J. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00529.x · Cited by 56
Localization of d-serine and serine racemase in neurons and neuroglias in mouse brain
Ding, X., Ma, N., Nagahama, M., Yamada, K., & Semba, R. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0422-2 · Cited by 54
NAAG, NMDA Receptor and Psychosis
Bergeron, R., & Coyle, J. T. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799462685 · Cited by 50
Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia
Goltsov, A. Y., Loseva, J. G., Андреева, Т. В., Grigorenko, A. P., Abramova, L. I., Каледа, В. Г., Александровна, О. В., Moliaka, Y. K., & Rogaev, E. I. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001801 · Cited by 50
Huang, M., Felix, A. R., Flood, D., Bhuvaneswaran, C., Hilt, D., Koenig, G., & Meltzer, H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3596-0 · Cited by 47
Modulation of behavior by scaffolding proteins of the post-synaptic density
Gao, C., Tronson, N. C., & Radulović, J. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.04.014 · Cited by 47
Metabotropic Glutamate Receptors for New Treatments in Schizophrenia
Herman, E. J., Bubser, M., Conn, P. J., & Jones, C. K. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_11 · Cited by 42
Yuan, Q., Yang, F., Xiao, Y., Tan, S., Husain, N., Ren, M., Hu, Z., Martinowich, K., Ng, J. S., Kim, P. J., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.019 · Cited by 39
Is There a Path Forward for mGlu2 Positive Allosteric Modulators for the Treatment of Schizophrenia?
Hopkins, C. R. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400023y · Cited by 36
Puhl, M. D., Mintzopoulos, D., Jensen, J. E., Gillis, T. E., Konopaske, G. T., Kaufman, M. J., & Coyle, J. T. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.009 · Cited by 35
Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning
Glen, W. B., Horowitz, B. L., Carlson, G. C., Cannon, T. D., Talbot, K., Jentsch, J. D., & Lavín, A. (2013) · Hippocampus · doi:10.1002/hipo.22215 · Cited by 34
D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog
Rojas, C. J., Alt, J., Ator, N. A., Thomas, A. G., Wu, Y., Hin, N., Wozniak, K. M., Ferraris, D. V., Rais, R., Tsukamoto, T., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.319 · Cited by 23
Cited by
Rare coding variants in ten genes confer substantial risk for schizophrenia
Singh, T., Poterba, T., Curtis, D., Akil, H., Al Eissa, M., Barchas, J. D., Bass, N., Bigdeli, T. B., Breen, G., Bromet, E. J., et al. (2022) · Nature · doi:10.1038/s41586-022-04556-w · Cited by 983
Glutamate hypothesis in schizophrenia
Uno, Y., & Coyle, J. T. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12823 · Cited by 367
Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation
Lü, W., Du, J., Goehring, A., & Gouaux, E. (2017) · Science · doi:10.1126/science.aal3729 · Cited by 176
Singh, T., Neale, B. M., & Daly, M. J. (2020) · doi:10.1101/2020.09.18.20192815 · Cited by 980
Livingston, N. R., Hawkins, P. C., Gilleen, J., Ye, R., Valdearenas, L., Shergill, S. S., & Mehta, M. A. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211000778 · Cited by 17
Metadata
- Authors
- Balu, D. T.
- Venue
- Advances in Pharmacology
- Publisher
- Elsevier
- Published
- 2016
- Volume
- 76
- Pages
- 351-382
- ISSN
- 1054-3589 (ISSN-L)
- OpenAlex
- W2339017320
- Cited by
- 285
- References
- 157
- FWCI
- 89.79
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.